JAMA Ophthalmology Author Interviews
Aflibercept Dose in Polypoidal Choroidal Vasculopathy
2025-12-18
Interview with Tien Y. Wong, MD, PhD, author of Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial. Hosted by Neil Bressler, MD.
Related Content:
- Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy
Comments (3)
More Episodes
All Episodes>>You may also like
Get this podcast on your phone, Free
Create Your Podcast In Minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Distribute to Apple Podcasts, Spotify, and more
- Make money with your podcast
It is Free
